Skip to main content

International Journal of Clinical Oncology

Ausgabe 8/2023

Including Invited Review on Diagnosis, treatment, and management of HPV-associated cancers: Similarities and Differences

Inhalt (16 Artikel)

Open Access Special Article

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors

Saori Mishima, Yoichi Naito, Kiwamu Akagi, Naomi Hayashi, Akira Hirasawa, Tomoro Hishiki, Ataru Igarashi, Masafumi Ikeda, Shigenori Kadowaki, Hiroaki Kajiyama, Motohiro Kato, Hirotsugu Kenmotsu, Yasuhiro Kodera, Keigo Komine, Takafumi Koyama, Osamu Maeda, Mitsuru Miyachi, Hiroshi Nishihara, Hiroyuki Nishiyama, Shouichi Ohga, Wataru Okamoto, Eiji Oki, Shigeru Ono, Masashi Sanada, Ikuo Sekine, Tadao Takano, Kayoko Tao, Keita Terashima, Katsuya Tsuchihara, Yasushi Yatabe, Takayuki Yoshino, Eishi Baba

Open Access Invited Review Article

Carcinogenesis and management of human papillomavirus-associated cervical cancer

Misako Kusakabe, Ayumi Taguchi, Kenbun Sone, Mayuyo Mori, Yutaka Osuga

Invited Review Article

Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in Japan

Kazutaka Yamada, Kouya Shiraishi, Atsuo Takashima, Daisuke Takayanagi, Yasumitsu Saiki, Shota Takano, Masafumi Tanaka, Mitsuko Fukunaga, Kosuke Sugimoto, Yuki Iwasaki, Yasushi Nakamura, Daisaku Kuwahara, Yoriyuki Tsuji, Masahiro Takano, Kenichi Sugihara, Yoichi Ajioka

Open Access Review Article

Opioids for the management of dyspnea in cancer patients: a systematic review and meta-analysis

Yusuke Takagi, Junya Sato, Yoshihiro Yamamoto, Ryo Matsunuma, Hiroaki Watanabe, Masanori Mori, Takaaki Hasegawa, Yoshinobu Matsuda, Jun Kako, Yoko Kasahara, Sho Goya, Hiroyuki Kohara, Takeo Nakayama, Takashi Yamaguchi

Original Article

Potential efficacy of local therapy for progressive lesions after nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

Masanobu Sato, Tomohiro Enokida, Akihisa Wada, Susumu Okano, Hideki Tanaka, Takao Fujisawa, Yuri Ueda, Atsushi Motegi, Takeshi Shinozaki, Naohiro Takeshita, Nobukazu Tanaka, Sadamoto Zenda, Kazuto Matsuura, Tetsuo Akimoto, Ryuichi Hayashi, Makoto Tahara

Original Article

Clinical utility of artificial intelligence assistance in histopathologic review of lymph node metastasis for gastric adenocarcinoma

Jun Matsushima, Tamotsu Sato, Yuichiro Yoshimura, Hiroyuki Mizutani, Shinichiro Koto, Keisuke Matsusaka, Jun-ichiro Ikeda, Taiki Sato, Akiko Fujii, Yuko Ono, Takashi Mitsui, Shinichi Ban, Hisahiro Matsubara, Hideki Hayashi

Open Access Original Article

Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer

Jun Imaizumi, Dai Shida, Narikazu Boku, Hiroshi Igaki, Jun Itami, Yasuji Miyakita, Yoshitaka Narita, Atsuo Takashima, Yukihide Kanemitsu

Original Article

Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study

Satoshi Dote, Eiji Shiwaku, Emiko Kohno, Ryohei Fujii, Keiji Mashimo, Naomi Morimoto, Masaki Yoshino, Naoki Odaira, Hiroaki Ikesue, Masaki Hirabatake, Katsuyuki Takahashi, Masaya Takahashi, Mari Takagi, Satoshi Nishiuma, Kaori Ito, Akane Shimato, Shoji Itakura, Yoshitaka Takahashi, Yutaka Negoro, Mina Shigemori, Hiroyuki Watanabe, Dai Hayasaka, Masahiko Nakao, Misaki Tasaka, Emi Goto, Noriaki Kataoka, Ayako Yokomizo, Ayako Kobayashi, Yoko Nakata, Mafumi Miyake, Yaeko Hayashi, Yoshie Yamamoto, Taiki Hirata, Kanako Azuma, Katsuya Makihara, Rino Fukui, Akira Tokutome, Keiji Yagisawa, Shinji Honda, Yuji Meguro, Shota Suzuki, Daisuke Yamaguchi, Hitomi Miyata, Yuka Kobayashi

Original Article

Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903)

Yoshinori Ito, Tetsuya Hamaguchi, Atsuo Takashima, Junki Mizusawa, Yasuhiro Shimada, Manabu Shiozawa, Nobutaka Mizoguchi, Takeshi Kodaira, Koji Komori, Masayuki Ohue, Koji Konishi, Fuminori Teraishi, Makoto Kinouchi, Kohei Murata, Fumihiko Fujita, Masahiko Watanabe, Gen Iinuma, Fumio Ishida, Yoshihisa Saida, Takahisa Matsuda, Hiroshi Katayama, Haruhiko Fukuda, Yukihide Kanemitsu

Original Article

Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study

Azusa Komori, Satoshi Otsu, Mototsugu Shimokawa, Taiga Otsuka, Futa Koga, Yujiro Ueda, Junichi Nakazawa, Shiho Arima, Masaru Fukahori, Yoshinobu Okabe, Akitaka Makiyama, Hiroki Taguchi, Takuya Honda, Taro Shibuki, Kenta Nio, Yasushi Ide, Norio Ureshino, Toshihiko Mizuta, Tsuyoshi Shirakawa, Kenji Mitsugi

Original Article

Preoperative HALP score is a prognostic factor for intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection: association with sarcopenia and immune microenvironment

Katsuya Toshida, Shinji Itoh, Yuki Nakayama, Yuriko Tsutsui, Yukiko Kosai-Fujimoto, Takahiro Tomino, Shohei Yoshiya, Yoshihiro Nagao, Noboru Harada, Kenichi Kohashi, Yoshinao Oda, Tomoharu Yoshizumi

Original Article

The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation

Soshi Kadena, Fumihiko Urabe, Kosuke Iwatani, Hirotaka Suzuki, Yu Imai, Kojiro Tashiro, Shunsuke Tsuzuki, Mariko Honda, Yusuke Koike, Tatsuya Shimomura, Manabu Aoki, Shun Sato, Hiroyuki Takahashi, Kenta Miki, Takahiro Kimura

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.